Registrato: 08/07/19 11:18
|Global Blood Typing , Grouping and Infectious Disease Screening Market Is Expected To Reach US$ 7,078.3 Mn By 2026
by aman · January 30, 2019
According to the latest report published by Credence Research, Inc.聽鈥淏lood Typing, Grouping and Infectious Disease Screening Market聽– Growth, Future Prospects and Competitive Analysis, 2018-2026,鈥澛爐he聽global blood typing, grouping and infectious disease screening market was valued at US$ 3,079.8 Mn in 2017 and expected to reach US$ 7,078.3 Mn by 2026, expanding at a CAGR of 9.7% from 2018 to 2026.
Browse the full聽report聽Blood Typing, Grouping and Infectious Disease Screening Market聽– Growth, Future Prospects and Competitive Analysis, 2018-2026 report at聽聽
The global blood typing, grouping and infectious disease screening market is projected to reach US$ 7,078.3 Mn by 2026 from US$ 3,079.8 Mn in 2017, growing at a CAGR of 9.7% during the forecast period from 2018 to 2026. The factors contributing to the market growth includes increase in disposable income, rising population, growing awareness regarding blood donations and blood products. According to the Centers for Disease Control and Prevention, the cases of syphilis, a disease caused by Treponema pallidum, has increased by 17.6% in 2016 accounting for 8.7 cases per 100,000 population in the United States. Furthermore, the growing rate of infections catalyze the market growth. According to the (a portal managed by the U.S. Department of Health & Human Services and supported by the Secretary鈥檚 Minority AIDS Initiative Fund (SMAIF)), the burden of HIV cases at the end of 2016 was reported around 36.7 million globally among which 2.1 million patients are less than 15 years of age. The global incident cases of HIV in 2016 was reported around 1.8 million that makes around 5,000 infections per day. The global blood typing, grouping and infectious disease screening market is segmented based on the test type, product type, infectious agent, and geography.
Based on the test type, the global market is segmented into ABO grouping, immunoassay screening and nucleic acid testing (NAT). In 2017, the market was dominated by the ABO grouping segment owing to the growing demand for blood & blood products, growing number of trauma cases and increasing usage of ABO blood grouping across other industries. Furthermore, NAT segment is identified as the fastest growing segment during the forecast period from 2018 to 2026. Based on the product type, the global market is segmented into kits, consumables and instruments. In 2017, consumables segment led the global market. Based on the infectious agent, the cytomegalovirus (CMV) led the market in 2017 owing to huge burden of infection cases.
Based the geographical segmentation, in 2017, North America led the global market with over 34% of the share, in terms of value. The supremacy of North America is attributed to the awareness among public regarding blood donations and infectious diseases. Furthermore, the treatment cost is higher compared to other parts of the world thereby making NA contribute majorly by value as compared to other regions. Asia Pacific is identified as the fastest growing region during the forecast period followed by the Latin America. Developing countries in these regions are the most potential markets such as India and Brazil that offers huge opportunities to the manufacturers.
The market is highly fragmented due to presence of several local and international manufacturers. No clear market leader is identified and the shares are distributed among the key players present in the market. The international players accounted more share than local players due to high market penetration, vast geographical outreach and diverse product portfolio. The key players in the market include Abbot Laboratories, Inc., Becton, Dickinson and Company, bioM茅rieux SA, Bio-Rad Laboratories, Inc., DiaSorin S.p.A, F. Hoffmann-La Roche Ltd., Grifols S.A, Immucor, Inc., Ortho Clinical Diagnostics, Quotient Ltd., and Thermo Fisher Scientific, Inc.
To know more insightful information, click here @聽 Advantages of Selecting a Custom Builder for Your Home
Posted by nouveauhomes on June 28th, 2017
Building your home with a professional is important. For this, you have to choose the right builder because it is the matter of safety of your home. On the internet, there are many agencies available who will provide the building service, but you can't understand by their profiles about their quality of work. For this, you have to consult with someone so that you can be assured about the builder’s authenticity. You can ask your friends and relatives to suggest a builder for your home. It will be better for you if you choose a builder near to your house so that you can easily contact with him. But there are both the large and small builders and you will always try to choose the bigger one, assured by the fact that they will serve you better than the other. But it is not true, rather if you will select the custom builder that will be fruitful for you. Here are some facts by which you can understand the advantages of selecting a small builder.
The custom builder does not deal with many projects at a time. So if you choose them then they can concentrate on your project and this will bring the quality to their work, which does not happen mostly with the large companies because they have many projects at a time and they do not have time to take special care on any project. So if you go near the smaller builder then they will try to make you satisfy wholeheartedly. At a big agency, there wil.